- Presentations
- 4
- Markets
- 1
Invokamet is a brand of Canagliflozin and Metformin marketed by Janssen Pharmaceuticals, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Canagliflozin and Metformin
- Brand owner
- Janssen Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 150 mg/1000 mg tablet, 150 mg/500 mg tablet, 50 mg/1000 mg tablet, 50 mg/500 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Invokamet 150 mg/1000 mg tabletOral | Janssen Pharmaceuticals | US FDA | Available on request |
| Invokamet 150 mg/500 mg tabletOral | Janssen Pharmaceuticals | US FDA | Available on request |
| Invokamet 50 mg/1000 mg tabletOral | Janssen Pharmaceuticals | US FDA | Available on request |
| Invokamet 50 mg/500 mg tabletOral | Janssen Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Canagliflozin and Metformin.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Invokamet
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.